Quantoom Biosciences

📍 Nivelles, Belgium👥 122 employees💰 Last funded Feb 2021
Biotechnology Research🌐 quantoom.com
Website LinkedIn
Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (Nfinity™) that encompasses DNA (Nplify™) and RNA (Ntensify™) manufacturing and formulation (Ncapsulate™), along with critical reagent supply, from sequence to large-scale production. We are a team of scientists, engineers, and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. Our facilities are strategically located in Belgium and France, in the heart of Europe, benefiting from an exceptional biotech ecosystem. Quantoom Biosciences is part of Univercells, a global life sciences Group with the mission of making biologics accessible to all.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Quantoom Biosciences?
Quantoom Biosciences has 1 investors on record on gritt.io.
When did Quantoom Biosciences last raise funding?
The most recent investment in Quantoom Biosciences recorded on gritt.io was in February 2021.
What industry is Quantoom Biosciences in?
Quantoom Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Quantoom Biosciences based?
Quantoom Biosciences is headquartered in Nivelles, Belgium.